EN DE
STOCK COMPARISON

IVIM Technology vs Abbott Laboratories: Fair Value & Quality

Both stocks run through our valuation models. Here is how IVIM Technology (460470) and Abbott Laboratories (ABT) compare, as of Sep 25, 2026.

As of Sep 25, 2026, Fair Value Calculator sees Abbott Laboratories as the less overvalued of the two: IVIM Technology trades at KRW 2,600 versus a fair value of KRW 1,197 (-54%), while Abbott Laboratories trades at $103 versus $74.79 (-28%).
IVIM Technology
460470.KQ · KRW · Health Care
-54%
upside to fair value
overvalued
PriceKRW 2,600
Fair ValueKRW 1,197
Quality39/100
Abbott Laboratories
ABT · USD · Health Care
-28%
upside to fair value
overvalued
Price$103
Fair Value$74.79
Quality66/100
Get comparisons like this free by email every month: the most undervalued quality stocks.

Head-to-head numbers

Green is the better side of a row, red the weaker one (for valuation multiples: lower = cheaper). Grey rows are for reference only and are not scored.

betterweakerfor reference, not scored

IVIM TechnologyAbbott Laboratories
Valuation
n/aP/E (TTM)28.5×
n/aP/S (TTM)4.01×
n/aP/B3.47×
n/aEV/EBITDA15.5×
n/aPEG1.47×
−54.0%Fair value upside−27.7%
n/aDividend yield2.4%
n/aDividend per share$2.44
Profitability
n/aOperating margin13%
n/aEBIT margin trend (5Y)1.19×
-13%Return on equity12%
-8%Return on assets6%
Growth
-49%Revenue growth (YoY)8%
48.4%Avg. growth/yr (3Y)0.5%
n/aAvg. growth/yr (5Y)5.1%
n/aValue creation/yr+10.6%
Balance & size
n/aInterest coverage (EBIT/interest)23.6×
0.03×Debt / equity0.19×
$30MMarket cap$181B
expensiveGrowth qualityhealthy

Abbott Laboratories leads: 2 to 3 metric wins.

n/a = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

IVIM Technologyof which business quality 39 · market factors 12 Abbott Laboratoriesof which business quality 66 · market factors 50
ProfitabilityMargins and returns on capital today
2
50
Quality GrowthAre margins and returns improving?
51
47
CashflowEarnings quality: real cash, not paper profit
14
71
Fin. StrengthBalance sheet, leverage, solvency risk
83
80
InvestmentDisciplined investing over empire-building
9
65
Low VolatilityCalm price path (market factor)
0
83
MomentumPrice trend over the last 3–12 months (market factor)
20
43
52W MomentumDistance to the 52-week high (market factor)
10
25
Net IssuanceShare count: buybacks or dilution?
80
84

What the models say

How far the median fair value (base case) per model family sits from the current price, in percent. The amount in the currency of the trading venue is shown underneath.

above the price, more than 15% above close to the price, 85% to 115% of the price below the price, more than 15% below

Model familyIVIM TechnologyPrice KRW 2,600Abbott LaboratoriesPrice $103
DCF Modelsn/a-28%below the price$74.80
Earnings-Basedn/a-72%below the price$29.42
Dividend Discountn/a-62%below the price$39.73
Multiplesn/a-32%below the price$70.72
Asset-Based-53%below the priceKRW 1,225-81%below the price$20.05
Growth DCFn/a-34%below the price$68.58
Economic Profitn/a-64%below the price$37.49
Growth Earningsn/a-32%below the price$70.25
Minimum-53%below the priceKRW 1,225-81%below the price$20.05
Maximum-53%below the priceKRW 1,225-28%below the price$74.80
Median-53%below the priceKRW 1,225-48%below the price$54.15
Geometric mean-53%below the priceKRW 1,225-55%below the price$46.64

Minimum, maximum, median and geometric mean refer to the family values in this table. Geometric because deviations are ratios: half the price and twice the price average to 100%, not 125%.

IVIM Technology: 1 of 1 models see the stock below the current price.

Abbott Laboratories: 26 of 26 models see the stock below the current price.

Scenario ranges

From our cautious bear scenario to the optimistic bull scenario. The white tick is the current price (value above it), the green tick the fair value (value below it): if the price sits left of the fair value, there is room to rise.

IVIM Technology
Price KRW 2,600
Fair Value KRW 1,197
Bear KRW 790Bull KRW 1,496
Abbott Laboratories
Price $103
Fair Value $74.79
Bear $52.12Bull $94.43

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

IVIM Technology · Health Care

Quality score39 · bottom 25%
Fair value upside-54% · below median

Abbott Laboratories · Health Care

Quality score66 · Top 25%
Fair value upside-28% · below median

Bottom line

As of Sep 25, 2026, Fair Value Calculator sees Abbott Laboratories as the less overvalued of the two: IVIM Technology trades at KRW 2,600 versus a fair value of KRW 1,197 (-54%), while Abbott Laboratories trades at $103 versus $74.79 (-28%).

Abbott Laboratories has the higher quality score (66/100).

Open Abbott Laboratories live analysis →

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 26 models. Values change with price and fundamentals; the date shown above applies.